Brief: Swedencare Buys Summit Veterinary Pharmaceuticals
24/03/2025 11:24
March 24 (Reuters) - Swedencare AB (publ) SECARE.ST: ACQUIRES SUMMIT VETERINARY PHARMACEUTICALS LIMITED, A LEADER IN THE UK’S THRIVING ANIMAL HEALTH SPECIALS MARKET INITIAL PURCHASE PRICE GBP 30 MILLION WITH TWO-YEAR EARN-OUT CASH CONSIDERATION GBP 27 MILLION AND 978,119 SHARES IN SWEDENCARE Source text: ID:nMFN6dPR2t Further company coverage: SECARE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Swedencare AB (publ)
See all newsSwedencare Q1 sales growth weighed by strong krona; sees dermatology segment growth later in FY
Brief: Swedencare Q1 Adjusted EBITDA SEK 127.7 Million
Brief: Swedencare Proposes Dividend Of 0.28 SEK Per Share
Swedencare Q4 revenue up 3%, EBITDA down 25%
petPhealthcare firm Swedencare's Q4 prelim revenue grows 11% organically